{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:02:02Z","timestamp":1791385322083,"version":"4.3.3"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017357","name":"Science and Technology Projects of Fujian Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.canlet.2024.216811","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:01:15Z","timestamp":1710316875000},"page":"216811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma"],"prefix":"10.1016","volume":"589","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6737-5231","authenticated-orcid":false,"given":"Shuimei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6949-2352","authenticated-orcid":false,"given":"Ziming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4134-5887","authenticated-orcid":false,"given":"Xianhe","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2021","key":"10.1016\/j.canlet.2024.216811_bib1","first-page":"209","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2024.216811_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrm3953","article-title":"Getting up to speed with transcription elongation by RNA polymerase II","volume":"16","author":"Jonkers","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216811_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-enhancer-driven transcriptional dependencies in cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3951","article-title":"The Mediator complex: a central integrator of transcription","volume":"16","author":"Allen","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216811_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrc.2016.62","article-title":"The role of enhancers in cancer","volume":"16","author":"Sur","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib7","article-title":"Super-enhancers: a new frontier for glioma treatment","volume":"1873","author":"Cheng","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2024.216811_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.3167","article-title":"What are super-enhancers?","volume":"47","author":"Pott","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.216811_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2019.02.014","article-title":"Super-enhancers in cancer","volume":"199","author":"Thandapani","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2024.216811_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.molcel.2015.02.014","article-title":"Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers","volume":"58","author":"Hnisz","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41588-019-0535-3","article-title":"WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating","volume":"51","author":"Scholz","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2024.216811_bib13","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.7150\/thno.45349","article-title":"Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.216811_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082137","article-title":"Epigenetic targeting of mcl-1 is synthetically lethal with Bcl-xL\/Bcl-2 inhibition in model systems of glioblastoma","volume":"12","author":"Shang","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.216811_bib15","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216811_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14802","article-title":"A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer","volume":"8","author":"Betancur","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib17","first-page":"2691","article-title":"Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32)","volume":"95","author":"Janssen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2024.216811_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.exphem.2010.09.002","article-title":"MYEOV is a prognostic factor in multiple myeloma","volume":"38","author":"Moreaux","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2024.216811_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.10765","article-title":"MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer","volume":"102","author":"Janssen","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s100380200065","article-title":"MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas","volume":"47","author":"Janssen","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.canlet.2024.216811_bib21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.bjc.6603054","article-title":"Net1 and Myeov: computationally identified mediators of gastric cancer","volume":"94","author":"Leyden","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbrc.2006.04.094","article-title":"ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion","volume":"345","author":"Moss","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12885-022-10433-6","article-title":"MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle\/c-Myc\/mTORC1 pathway","volume":"23","author":"Tange","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41388-018-0484-9","article-title":"MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-\u03b2 pathway in NSCLC","volume":"38","author":"Fang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216811_bib25","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1038\/s41388-020-01443-4","article-title":"MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity","volume":"39","author":"Liang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216811_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41419-021-04387-z","article-title":"The MYEOV-MYC association promotes oncogenic miR-17\/93-5p expression in pancreatic ductal adenocarcinoma","volume":"13","author":"Shen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216811_bib27","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216811_bib28","first-page":"4109","article-title":"Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice","volume":"46","author":"Naito","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216811_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216811_bib30","doi-asserted-by":"crossref","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","article-title":"New developments on the Encyclopedia of DNA Elements (ENCODE) data portal","volume":"48","author":"Luo","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216811_bib31","doi-asserted-by":"crossref","first-page":"W158","DOI":"10.1093\/nar\/gkz348","article-title":"WashU epigenome browser update 2019","volume":"47","author":"Li","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216811_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41389-020-00277-9","article-title":"Aberrant super-enhancer landscape reveals core transcriptional regulatory circuitry in lung adenocarcinoma","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2024.216811_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/mc.23419","article-title":"Functional characterization and clinical significance of super-enhancers in lung adenocarcinoma","volume":"61","author":"Jiang","year":"2022","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2024.216811_bib34","doi-asserted-by":"crossref","first-page":"D280","DOI":"10.1093\/nar\/gkac968","article-title":"SEdb 2.0: a comprehensive super-enhancer database of human and mouse","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216811_bib35","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1074\/jbc.RA119.011869","article-title":"The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity","volume":"295","author":"Huang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216811_bib36","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1007\/s12010-023-04444-7","article-title":"MiRNA-30a-5p\/VCAN Arrests tumor metastasis via modulating the adhesion of lung adenocarcinoma cells","volume":"195","author":"Qin","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.canlet.2024.216811_bib37","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s10147-020-01696-9","article-title":"FAM83A drives PD-L1 expression via ERK signaling and FAM83A\/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma","volume":"25","author":"Zhou","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216811_bib38","first-page":"4264","article-title":"Overexpression of family with sequence similarity 83, member A (FAM83A) predicts poor clinical outcomes in lung adenocarcinoma","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.canlet.2024.216811_bib39","first-page":"321","article-title":"Up-regulation of insulin-like growth factor binding protein-3 is associated with brain metastasis in lung adenocarcinoma","volume":"42","author":"Yang","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2024.216811_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer","volume":"8","author":"Gy\u0151rffy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2024.216811_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13059-015-0831-x","article-title":"HiC-Pro: an optimized and flexible pipeline for Hi-C data processing","volume":"16","author":"Servant","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2024.216811_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13577-019-00302-z","article-title":"MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV","volume":"33","author":"Wang","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib43","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1186\/s12864-021-08137-5","article-title":"Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma","volume":"22","author":"Wu","year":"2021","journal-title":"BMC Genom."},{"key":"10.1016\/j.canlet.2024.216811_bib44","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gkac935","article-title":"FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.216811_bib45","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1074\/jbc.M110.155234","article-title":"A novel mechanism of lysosomal acid sphingomyelinase maturation: requirement for carboxyl-terminal proteolytic processing","volume":"286","author":"Jenkins","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216811_bib46","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1074\/jbc.273.29.18250","article-title":"The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene","volume":"273","author":"Schissel","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216811_bib47","doi-asserted-by":"crossref","first-page":"35706","DOI":"10.1074\/jbc.M110.125609","article-title":"Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation","volume":"285","author":"Jenkins","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216811_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-020-03297-w","article-title":"Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis","volume":"12","author":"Thayyullathil","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216811_bib49","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41467-020-14916-7","article-title":"Dynamic CpG methylation delineates subregions within super-enhancers selectively decommissioned at the exit from naive pluripotency","volume":"11","author":"Bell","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2020.08.020","article-title":"A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancer","volume":"38","author":"Chen","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib51","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/s41467-021-22445-0","article-title":"Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-019-0757-y","article-title":"Super-enhancers: critical roles and therapeutic targets in hematologic malignancies","volume":"12","author":"Jia","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.216811_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12983","article-title":"Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity","volume":"7","author":"Ooi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/0008-5472.CAN-21-0921","article-title":"Super enhancer-mediated upregulation of HJURP promotes growth and survival of t(4;14)-positive multiple myeloma","volume":"82","author":"Jia","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216811_bib55","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13046-022-02428-9","article-title":"Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia","volume":"41","author":"Fang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216811_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163592","article-title":"Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling","volume":"133","author":"Lee","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216811_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12943-020-01236-z","article-title":"Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma","volume":"19","author":"Deng","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.216811_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-022-01331-2","article-title":"Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-\u03b2\/SMAD3 pathway","volume":"15","author":"Zhang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2024.216811_bib59","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1080\/15384101.2020.1757243","article-title":"Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma","volume":"19","author":"Tang","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2024.216811_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1756-9966-29-81","article-title":"MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2","volume":"29","author":"Lawlor","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216811_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib62","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1021\/acsnano.3c01369","article-title":"Tumor-generated reactive oxygen species storm for high-performance ferroptosis therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.canlet.2024.216811_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216811_bib64","series-title":"NIR-Promoted Ferrous Ion Regeneration Enhances Ferroptosis for Glioblastoma Treatment","author":"Xue","year":"2024"},{"key":"10.1016\/j.canlet.2024.216811_bib65","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216811_bib67","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2024.216811_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163448","article-title":"Targeting fatty acid metabolism in glioblastoma","volume":"133","author":"Miska","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2024.216811_bib69","doi-asserted-by":"crossref","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2024.216811_bib70","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGF\u03b22-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216811_bib71","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1101\/gad.314674.118","article-title":"Regulation of lipid peroxidation and ferroptosis in diverse species","volume":"32","author":"Conrad","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2024.216811_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216811_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216811_bib74","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2024.216811_bib75","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1194\/jlr.M054528","article-title":"Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2","volume":"55","author":"Oninla","year":"2014","journal-title":"J. Lipid Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T19:09:10Z","timestamp":1714072150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524002040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":75,"alternative-id":["S0304383524002040"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216811","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216811"}}